Eyal Baumel

Eyal Baumel operates as a San Francisco-based solo angel writing $25k-$100k checks at the pre-seed and seed stages, with a stated focus that spans digital health, AI/ML in healthcare, and consumer wellness. His public footprint is thin beyond an NFX Signal profile and a LinkedIn presence, which is typical for angels who deploy through warm intros rather than inbound. The check size signals he’s most useful as a small participant in a syndicate or party round rather than a price-setter, and the AI lean suggests he’s more comfortable evaluating software-led healthcare bets than capital-intensive biotech or device plays. Founders building consumer-facing digital health products, AI-enabled clinical workflows, or wellness platforms with a Bay Area gravity should consider him a potential add to a round that already has an institutional lead. He is unlikely to be the right call for therapeutics, regulated medical devices, or anything requiring deep regulatory navigation. Approach via LinkedIn with a tight one-paragraph note that frames the company in language an operator-angel will recognize, ideally with a mutual contact in the SF early-stage ecosystem to make the introduction. Without an explicit thesis statement or visible portfolio narrative, founders should treat this profile as a directional signal rather than a confirmed fit and prioritize their time accordingly. He is best evaluated as filler capital alongside a stronger lead investor.